INS and Obesity: In this regard, Luchsinger et al. [39] showed a slight arrest in cognitive decline related to lowered fasting insulin levels in middle-aged (65 years) non-diabetic patients with obesity (BMI 31 kg/m2) after 12 months of treatment with metformin.